Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Type2diabetes Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

8 recruiting trials for Type2diabetes. Eligibility criteria explained in plain English.

TrialFinderData lists 8 Type2diabetes clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Across the trials that carry a phase, Phase 4 is the largest group at 33% (1 studies); the largest phase groups are Phase 4: 1, Early Phase 1: 1, Phase 2: 1.

Research is led by Johns Hopkins University (1), All India Institute of Medical Sciences, Bhubaneswar (1), Brigham and Women's Hospital (1), among the most active sponsors registered for these trials.

The most frequently studied intervention is Community Champions (behavioral, 1 trial), followed by Homegrown Heroes, Mini gastric bypass surgery.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
8
Total Trials
8
Recruiting Now
0
Phase 3 Trials
8
Sponsors

Track Type2diabetes trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT06364644

Understanding and Addressing Risks of Low Socioeconomic Status and Diabetes for Heart Failure

This study aims to determine whether a 6-month multilevel intervention involving problem-solving training, exercise training and support from community health workers is more...

Sponsor: Johns Hopkins UniversityEnrolling: 2102 locations
RECRUITINGNCT06015620

Comorbidities Resolution After MGB Surgery and Change in Body Composition

This observational study aims to learn about the correlation between the improving comorbidities associated with obesity after MGB (Mini-Gastric Bypass) surgery and changes in...

Sponsor: All India Institute of Medical Sciences, BhubaneswarEnrolling: 351 location
RECRUITINGPhase 4NCT05390892

PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

PRECIDENTD is a randomized, open label, pragmatic clinical trial designed to compare rates of the total number of cardiovascular, kidney, and death events among two alternative...

Sponsor: Brigham and Women's HospitalEnrolling: 600020 locations
RECRUITINGNCT05909046

A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE

DIP : To conduct a pragmatic, non-blinded randomized controlled trial (pRCT) of immediate in-patient postpartum OGTT prior to delivery discharge (intervention) versus 4-12 week...

Sponsor: Ohio State UniversityEnrolling: 1041 location
RECRUITINGEarly Phase 1NCT06322212

Type 2 Diabetes and Blood Brain Barrier Improvement

The majority of T2DM adults show thiamine (vitamin B1) deficiency which may contribute to impaired function. This study will examine patients with T2DM through brain MRI scans,...

Sponsor: University of California, Los AngelesEnrolling: 521 location
RECRUITINGNCT06337812

Fiber Supplementation in Heart Failure With Preserved Ejection Fraction (HFpEF)

The study team is studying how increasing dietary fiber, specifically through adding potato starch to participant's diet, may impact the species of bacteria in participant's gut...

Sponsor: University of MichiganEnrolling: 301 location
RECRUITINGNCT06469437

The Impact of Geriatric Assessment on the Treatment Plan of Elderly Patients With T2DM

Introduction: With the aging of the world population and the increasing incidence of type 2 diabetes mellitus (T2DM) with age, the number of elderly individuals living with...

Sponsor: Hospital de Clinicas de Porto AlegreEnrolling: 2201 location
RECRUITINGPhase 2NCT05499702

The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction

Caloric restriction (and RYGB) improves insulin action and lowers fasting glucose, glucagon and EGP, without changes in postprandial EGP and glucagon concentrations. Caloric...

Sponsor: Adrian VellaEnrolling: 201 location

Frequently Asked Questions

There are currently 8 clinical trials for Type2diabetes, with 8 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Type2diabetes, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Type2diabetes, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.